1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Cystinosis Global Clinical Trials Review, H1, 2015

Cystinosis Global Clinical Trials Review, H1, 2015

  • January 2015
  • -
  • Global Data
  • -
  • 60 pages

Cystinosis Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Cystinosis Global Clinical Trials Review, H1, 2015" provides data on the Cystinosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cystinosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cystinosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Cystinosis Global Clinical Trials Review, H1, 2015
Table of Contents
Introduction 5
Cystinosis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Central and South America 11
Clinical Trials by G7 Countries: Proportion of Cystinosis to Genetic Disorders Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Cystinosis to Genetic Disorders Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Prominent Drugs 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Raptor Pharmaceuticals Corp. 24
Clinical Trial Overview of Raptor Pharmaceuticals Corp. 24
Clinical Trial Overview of Top Institutes / Government 25
National Human Genome Research Institute 25
Clinical Trial Overview of National Human Genome Research Institute 25
National Eye Institute 26
Clinical Trial Overview of National Eye Institute 26
Vall d'Hebron University Hospital 27
Clinical Trial Overview of Vall d'Hebron University Hospital 27
FDA Office of Orphan Products Development 28
Clinical Trial Overview of FDA Office of Orphan Products Development 28
Centre Hospitalier Universitaire de Nice 29
Clinical Trial Overview of Centre Hospitalier Universitaire de Nice 29
University of California, San Diego 30
Clinical Trial Overview of University of California, San Diego 30
University of Sao Paulo 31
Clinical Trial Overview of University of Sao Paulo 31
The National Institute of Diabetes and Digestive and Kidney Diseases 32
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 32
Hospices Civils de Lyon 33
Clinical Trial Overview of Hospices Civils de Lyon 33
Five Key Clinical Profiles 34
Appendix 58
Abbreviations 58
Definitions 58
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Source 60

List of Tables

Cystinosis Therapeutics, Global, Clinical Trials by Region, 2015* 6
Cystinosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Cystinosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Cystinosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 9
Cystinosis Therapeutics Clinical Trials, North America, Top Countries, 2015* 10
Cystinosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 11
Proportion of Cystinosis to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 12
Cystinosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Cystinosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Proportion of Cystinosis to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 15
Cystinosis Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Cystinosis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17
Cystinosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Cystinosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Cystinosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 20
Cystinosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 21
Cystinosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 22
Cystinosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23
Cystinosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Raptor Pharmaceuticals Corp., 2015* 24
Cystinosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Human Genome Research Institute, 2015* 25
Cystinosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 26
Cystinosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Vall d'Hebron University Hospital, 2015* 27
Cystinosis Therapeutics Clinical Trials Market, Global, Clinical Trials by FDA Office of Orphan Products Development, 2015* 28
Cystinosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nice, 2015* 29
Cystinosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2015* 30
Cystinosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2015* 31
Cystinosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 32
Cystinosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2015* 33

List of Figures

Cystinosis Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Cystinosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Cystinosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Cystinosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 9
Proportion of Cystinosis to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 12
Cystinosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Cystinosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Proportion of Cystinosis to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 15
Cystinosis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Cystinosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17
Cystinosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Cystinosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Cystinosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 20
Cystinosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 21
Cystinosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23
GlobalData Methodology 59

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.